Predicting cognitive impairment in high-functioning community-dwelling older persons: MacArthur studies of successful aging

Journal of the American Geriatrics Society

Volumn 50, Issue 6, 2002, Pages 1051-1060

  Chodosh, Joshua ^a   Reuben, David B ^a   Albert, Marilyn S ^b   Seeman, Teresa E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Cognitive impairment; Dementia

Indexed keywords

AGE; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; COMMUNITY; CONFIDENCE INTERVAL; DEMENTIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PSYCHOLOGIC TEST; QUESTIONNAIRE; RECALL; RECOGNITION; SCORING SYSTEM; UNITED STATES;

AGED; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; INTELLIGENCE TESTS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 0036081734     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.2002.50260.x     Document Type: Article

References (76)

1. Estimated prevalence of Alzheimer's disease in the United States
2. Donepezil therapy in clinical practice: A randomized crossover study
3. The effects of donepezil in Alzheimer's disease - Results from a multinational trial
4. Metrifonate therapy in Alzheimer's disease: A pooled analysis of four randomized, double-blind, placebo-controlled trials
5. Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension
6. Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living
7. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients
8. Selegiline in the treatment of Alzheimer's disease: A long-term randomized placebo-controlled trial
9. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
10. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society
11. Dementia
12. Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome
13. Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease
14. Memory and aging: Four hypotheses in search of data
15. Very mild senile dementia of the Alzheimet type. I. Clinical assessment
16. Predicting conversion to Alzheimer disease using standardized clinical information
17. Cued recall and eatly identification of dementia
18. Preclinical cognitive markers of dementia of the Alzheimer type
19. Memory function in very early Alzheimer's disease
20. Predictors of cognitive change in middle-aged and older adults with memory loss
21. Mnemonics usage and cognitive decline in age-associated memory impairment
22. Neuropsychological detection and characterization of preclinical Alzheimer's disease
23. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old
24. A prospective study of cognitive function and onset of dementia in cognitively healthy elders
25. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons
26. Questionable dementia: Clinical course and predictors of outcome
27. Cognitive predictors of incident Alzheimer's disease: A prospective longitudinal study
28. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study
29. Progression to dementia in patients with isolated memory loss
30. High, usual, and impaired functioning: Findings from the MacArthur Foundation Reasearch Network on Successful Aging multi-site study of community-dwelling elderly
31. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients
32. An epidemiology of disability among adults in the United States. Milbank Memorial Fund Quarterly
33. A Guttman health scale for the aged
34. Short portable mental status questionnaire as a screening test for dementia and delirium among the elderly
35. Postoperative mental impairment in hip fracture patients. A randomized study of reorientation measures in 223 patients
36. Depressive symptomatology and incident cognitive decline in an elderly community sample
37. Impact of estrogen use on decline in cognitive function in a representative sample of older community resident women
38. Memory complaint as a predictor of cognitive decline: A comparison of African American and White elders
39. Association of education with incidence of cognitive impairment in three Established Populations for Epidemiologic Studies of the Elderly
40. Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents
41. A verbal memory test with high predictive accuracy for dementia of the Alzheimer type
42. Comparison of verbal fluency tasks in detection of dementia of the Alzheimer type
43. Use of brief cognitive tests identify individuals in the community with clinically diagnosed Alzheimer's disease
44. Cognitive performance in a high-functioning community-dwelling elderly population
45. Dementia: Age-dependent incidence, prevalence and mortality in the old old
46. The CES-D scale: A self-report depression scale for research in the general population
47. Assessing depressive symptoms in five psychiatric populations: A validation study
48. Use of a self-report symptom scale to detect depression in a community sample
49. The prevalence of depression and its correlates in older adults
50. Two shorter forms of the CES-D depression symptoms index
51. Exploring the effect of depression on physical disability: Longitudinal evidence from the Established Populations for Epidemiologic Studies of the Elderly
52. Determinants of change in perceived health in a longitudinal study of older adults
53. History of depression as a risk factor for Alzheimer's disease
54. Self-efficacy beliefs and change in cognitive preformance: MacArthur Studies of Successful Aging
55. Central auditory dysfunction, cognitive dysfunction, and dementia in older people
56. Peak expiratory flow rate and 5-year mortality in an elderly population
57. Influence of social network on occurrence of dementia: A community-based longitudinal study
58. Social disengagement and incident cognitive decline in community-dwelling elderly persons
59. Predictors of cognitive change in older persons: MacArthur studies of successful aging
60. The bootstrap method for assessing statistical accuracy
61. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neurological measures
62. Practice parameter: Mild cognitive impairment (an evidence-based review). Report on the quality standards subcommittee of the American Academy of Neurology
63. Very mild senile dementia of the Alzheimer type II: Psychometric test performance
64. Education and occupation as risk factors for dementia: A population-based case-control study
65. Functional status, education, and the diagnosis of dementia in the Shanghai survey
66. Level of education and change in cognitive function in a community population of older persons
67. Influence of education and occupation on the incidence of Alzheimer's disease
68. Education and the prevalence of dementia and Alzheimer's disease
69. Psychiatric history and related exposures as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies
70. Clinical risk factors for Alzheimer's disease: A population-based case-control study
71. The occurrence of depressive symproms in the preclinical phase of AD: A population-based study
72. Depressive symptoms and cognitive decline in nondemenred elderly women: A prospective study